Ever Source Wealth Advisors, LLC Nektar Therapeutics Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 810 shares of NKTR stock, worth $19,116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
810
Previous 1,391
41.77%
Holding current value
$19,116
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NKTR
# of Institutions
22Shares Held
16.1MCall Options Held
17.2KPut Options Held
0-
Black Rock Inc. New York, NY15.2MShares$358 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY491KShares$11.6 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL327KShares$7.71 Million0.0% of portfolio
-
Vista Wealth Management Group, LLC51.5KShares$1.22 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ18.6KShares$438,1810.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $4.42B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...